Inspire Medical Systems, Inc. (INSP) Dividend History

Inspire Medical Systems, Inc. develops and commercializes medical devices for the treatment of sleep apnea. The company's flagship device, the Inspire Therapy system, uses neurostimulation technology to stimulate the hypoglossal nerve, helping to keep the airway open during sleep. Founded in 2007 and headquartered in Minneapolis, Minnesota, Inspire aims to provide an alternative to traditional sleep apnea treatments such as CPAP machines.

5500 Wayzata Blvd, Golden Valley, MN, 55416
Phone: 763-957-5037
Website: https://www.inspiresleep.com

Dividend History

Inspire Medical Systems, Inc. currently does not pay dividends

Company News

  • Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference

    Inspire Medical Systems will present at the Wells Fargo 2025 Healthcare Conference on September 3, 2025, discussing their innovative neurostimulation technology for treating obstructive sleep apnea.

    GlobeNewswire Inc.
  • Nyxoah Q2 Revenue Jumps 74 Percent

    Nyxoah received FDA Pre-Market Approval for its GENEO system to treat obstructive sleep apnea, launching a 50-person commercial team targeting high-volume U.S. implanting centers with 73.8% year-over-year revenue growth.

    The Motley Fool
    Featured Companies: NYXH
  • Inspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval - Zacks Investment Research

    Inspire Medical Systems has received CE mark certification for its Inspire therapy under the European Union's Medical Device Regulation (EU MDR), which is a significant milestone for the company's expansion in the global obstructive sleep apnea treatment market.

    Zacks Investment Research
    Featured Companies: BSX GMED SYK
  • Joby Aviation executive Kate DeHoff sells shares worth over $108k By Investing.com - Investing.com Canada

    Mizuho Securities reduced its price target for Inspire Medical Systems (INSP) from $250 to $200, citing a valuation change after the SURMOUNT-OSA study results. However, the firm maintained an Outperform rating on the company's shares.

    Investing.com
  • Expert Ratings For Inspire Medical Systems

    In the latest quarter, 6 analysts provided ratings for Inspire Medical Systems (NYSE:INSP), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 3 1 0 0 Last 30D 0 0 1 0 0 1M Ago 0 1 0 0 0 2M Ago 0 1 0 0 0 3M Ago 2 1 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $250.83, a high estimate of $285.00, and a low estimate of $185.00. Witnessing a positive shift, the current average has risen by 3.79% from the previous average price target of $241.67. Exploring Analyst Ratings: An In-Depth Overview The perception of Inspire Medical Systems by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Bob Hopkins B of A Securities Lowers Neutral $185.00 $225.00 Adam Maeder Piper Sandler Raises Overweight $255.00 $250.00 Shagun Singh RBC Capital Announces Outperform $285.00 - Anthony Petrone Mizuho Maintains Buy $250.00 $250.00 Richard Newitter Truist Securities Maintains Buy $280.00 - Kallum Titchmarsh Morgan Stanley Announces Overweight $250.00 - Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments ...Full story available on Benzinga.com

    Benzinga
Page data last updated 09/07/2025 04:11:57 UTC